Quality use of medicines activities in New Zealand hospitals from 2000 to 2002

New Zealand Medical Journal

Volumn 118, Issue 1208, 2005, Pages

  Tordoff, June ^a   Norris, Pauline ^a   Kennedy, Julia ^b   Reith, David ^c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

CENTRALIZATION; CLINICAL PHARMACY; CONTROLLED STUDY; DRUG COST; DRUG FORMULARY; DRUG INFORMATION; DRUG USE; HEALTH BEHAVIOR; HEALTH CARE QUALITY; HEALTH SURVEY; HOSPITAL PERSONNEL; HOSPITAL SERVICE; HUMAN; MANAGER; NEW ZEALAND; NURSING; PHARMACIST; PRACTICE GUIDELINE; PUBLIC HOSPITAL; QUESTIONNAIRE; REVIEW; STATISTICAL ANALYSIS; ARTICLE; CROSS-SECTIONAL STUDY; DRUG UTILIZATION; ECONOMICS; HOSPITAL PHARMACY; PUBLICATION; SAFETY; STANDARD;

CROSS-SECTIONAL STUDIES; DRUG COSTS; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; FORMULARIES, HOSPITAL; NEW ZEALAND; PHARMACY SERVICE, HOSPITAL; QUESTIONNAIRES; SAFETY MANAGEMENT;

EID: 17144405690     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. World Health Organization. Report of the conference of experts. In: The rational use of drugs. Report of the conference of experts, November 1985, Nairobi. Geneva: WHO; 1986.
2. Quick JD, Laing Ro, and Ross-Dengen DG, Intervention research to promote clinically effective and economically efficient use of pharmaceuticals: the International Network for Rational Use of Drugs. J Clin Epidemiol. 1991;44(Suppl 2):57S-65S.
3. Werko L, The rational use of medicines. Int J Technol Assess Health Care. 1995;11:391-8.
4. Commonwealth Department of Health and Housing and Community Services, A policy on the quality use of medicines. Canberra: Commonwealth Department of Health, Housing and Community Services; 1992.
5. Maling TJ. The New Zealand preferred medicines concept: a national scheme for audit and quality assurance of prescribing. Pharmacoeconomics. 1994;6:5-14.
6. Maling TJB, Ferguson RI, Bryant L. Prescribing by consensus: the Wellington Hospital Board preferred medicines list. N Z Med J. 1988;101:8-10.
7. Pearce MJ, Begg EJ. Encouraging consensus cost effective drug therapy: five years experience with a hospital drug utilisation review programme. N Z Med J. 1997;110:92-5.
8. Pharmaceutical Management Agency. National Hospital Pharmaceutical Strategy Final Version. Wellington, NZ: PHARMAC; 2002.
9. Stata Corporation, Intercooled Stata Version 8 for Windows. College Station, TX 77840: Stata Corporation; 2003.
10. Adam B, The challenges of running a District Health Board, in Continuity amid chaos, Gould R, Editor. Dunedin: University of Otago Press; 2003:28-9.
11. Pearce MJ, Begg EJ. A review of limited lists and formularies. Are they cost-effective? Pharmacoeconomics. 1992;1:191-202.
12. Plumridge RJ, Stoelwinder JU, Rucker TD. Drug and therapeutics committees: relationships among structure, function, and effectiveness. Hospital Pharmacy. 1993;28:492-3.
13. Weekes LM, Brooks C. Drug and Therapeutics Committees in Australia: expected and actual performance. Br J ClinPharmacol. 1996; 42:551-7.
14. Cotter SM, Barber ND, McKee M. Survey of clinical pharmacy services in United Kingdom National Health Service hospitals. Am J Hosp Pharm. 1994;51:2676-84.
15. Mannebach MA, Ascione FJ, Gaither CA, et al. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals. Am J Health Syst Pharm. 1999. 56:622-8.
16. Pedersen CA, Schneider PJ, Santell JP. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing-2001. Am J Health Syst Pharm. 2001;58:2251-66.
17. Misan GM, Dollman C, Shaw DR, Burgess N. Cephalosporin utilisation review and evaluation. Pharmacoeconomics. 1995;8:100-22.
18. Stevenson JG, Bakst CM, Zaran FK, et al. Quality improvement in the use of medications through a drug evaluation service. Top Hosp Pharm Manage. 1992;12:47-56.
19. Oxman AD, Thomson MA, Davis DA, Haynes RB. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. CMAJ. 1995;153:1423-31.
20. Soumerai SB, McLaughlin TJ, Avorn J. Quality assurance for drug prescribing. Qual Assur Health Care. 1990;2:37-58.
21. Rascati KL. Survey of formulary system policies and procedures. Am J Hosp Pharm. 1992;49:100-3.
22. Sloan FA, Whetton-Goldstein K, Wilson A. Hospital pharmacy decisions, cost containment, and the use of cost-effectiveness analysis. Soc Sci Med. 1997;45:523-33.
23. Thurmann PA, Harder S, Steioff A. Structure and activities of hospital drug committees in Germany. Eur J Clin Pharmacol. 1997;52:429-35.
24. Fijn R, de Jong-van den Berg LT, Brouwers JR. Rational pharmacotherapy in the Netherlands: formulary management in Dutch hospitals. Pharm World Sci. 1999;21:74-9.
25. Fijn R, de Vries CS, Engels SA, et al. The quality of Dutch hospital drug formularies: evaluation of technical features and organisational information. Pharm World Sci. 1999;21:120-6.
26. Odedina FT, Sullivan J, Nash R, Clemmons CD. Use of pharmacoeconomic data in making hospital formulary decisions. Am J Health Syst Pharm. 2002;59:1441-4.
27. Drummond M, Cooke J, Walley T. Economic evaluation under managed competition: evidence from the UK. Soc Sci Med. 1997;45:583-95.
28. Hoffmann C, Stoykova BA, Nixon J, et al., Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities. Value in Health. 2002;5:71-8.
29. Bond CA, Raehl CL, Franke R. Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals. Pharmacotherapy. 2000;20:609-21.